endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1h-indazole-3-carbo-xamide hydrochloride
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 28, 2001
app pub date -
Apr 13, 2000
filing date -
Jun 24, 1997
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Invented are improved solid dosage formulations of endo-N-(9-methyl-9-azab-icyclo[3.3.1.]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride. Also invented is an imporved method of administering an anti-emeticly effective amount of the compound endo-N-(9-methyl-9-azabicyclo[3.3.1.]non--3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully